Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
To view the full list of supported financial metrics please see Complete Metrics Listing.
Relative Strength Index (14D) is a momentum oscillator that measures the speed and change of price movements.
We use a most popular implementation of RSI which looks at a 14-day timeframe. Index scores range from 0 to 100, where the stock is considered overbought when the index is above 70 and oversold when below 30. Anika Therapeutics’s 14 day RSI of 39.68 suggests the company is trading in technically neutral territory.
RSI was described in J. Welles Wilder’s published work, New Concepts in Technical Trading Systems, and in Commodities magazine in the June 1978 issue and has last the test of time becoming one of the more widely used oscillator indices. Read more about relative strength index here.
The chart above depicts the distribution of Relative Strength Index (14d) for companies operating in the Healthcare Sector in the Developed economic region. Over 2,610 companies were considered in this analysis, and 2,565 had meaningful values. The average Relative Strength Index (14d) of companies in the Sector is 47.52 with a standard deviation of 15.19. Please note that Sector and Industry values may differ from other sources, as no adjustments have been made.
Anika Therapeutics Inc's Relative Strength Index (14d) of 39.68 ranks in the 29.4% percentile for the Sector. The following table provides additional summary stats:
| Economic Risk Region | Developed |
| Total Constituents | 2,617 |
| Included Constituents | 2,565 |
| Min | 20.17 |
| Max | 100.00 |
| Median | 45.73 |
| Mean | 47.52 |
| Standard Deviation | 15.19 |
You can find companies with similar Relative Strength Index (14d) using this stock screener.
The video below provides an overview of the key benefits to help you get the most out of InvestingPro.